Peroxisomicine A2

(2′R,6S)-1,2′,5′,6,9,10′-Hexahydroxy-2′,6-dimethyl-2′,3′,6,7-tetrahydro-2,9′-bianthracen-4′,8(1′H,5H)-dion

(2′R,6S)-1,2′,5′,6,9,10′-Hexahydroxy-2′,6-dimethyl-2′,3′,6,7-tetrahydro-2,9′-bianthracene-4′,8(1′H,5H)-dione

(2′R,6S)-1,2′,5′,6,9,10′-Hexahydroxy-2′,6-diméthyl-2′,3′,6,7-tétrahydro-2,9′-bianthracène-4′,8(1′H,5H)-dione

156768-16-0

[2,9′-Bianthracene]-4′,8(1′H,5H)-dione, 2′,3′,6,7-tetrahydro-1,2′,5′,6,9,10′-hexahydroxy-2′,6-dimethyl-, (2′R,6S)-

Peroxisomicine A2

(2,9′-Bianthracene-4′,8(1′H,5H)-dione, 2′,3′,6,7-tetrahydro-2′,6-dimethyl-1,2′,5′,6,9,10′-hexahydroxy-

(3R)-3,8,9-trihydroxy-3-methyl-10-[(6S)-1,6,9-trihydroxy-6-methyl-8-oxo-5,7-dihydroanthracen-2-yl]-2,4-dihydroanthracen-1-one

(3R)-3,8,9-trihydroxy-3-methyl-10-[(6S)-1,6,9-trihydroxy-8-keto-6-methyl-5,7-dihydroanthracen-2-yl]-2,4-dihydroanthracen-1-one

Diast T-514

Peroxisomicin A2

T 514′